Map Pharmaceuticals, (MAPP)

Trade MAPP now with

RTTNews Articles

Date	Headline
3/1/2013 9:02:38 AM	Allergan Announces Expiration Of Tender Offer For All Outstanding Shares Of MAP Pharmaceuticals
2/7/2013 9:07:44 AM	Allergan, MAP Say Federal Trade Commission Granted Early Termination Of Waiting Period Under Hart-Scott-Rodino Act
1/31/2013 9:09:20 AM	Allergan Begins Tender Offer To Buy MAP Pharma's Outstanding Shares
1/31/2013 9:03:18 AM	Allergan Commences Tender Offer To Purchase All Outstanding Common Shares Of MAP Pharmaceuticals
1/26/2013 12:01:38 PM	Law Office Of Brodsky & Smith, LLC Announces Investigation Of MAP Pharmaceuticals
1/24/2013 6:31:30 AM	MAP Pharmaceuticals Inc. (MAPP) Leaped To A New High After Merger Announcement
1/23/2013 9:40:42 AM	MAP Pharmaceuticals Inc. (MAPP) Has Jumped To A New High On Merger News
1/23/2013 4:10:31 AM	MAPP Bought Out, TELK Rises, TSOI, AMPE Begin Anew, EDAP On High, CLSN Heats Up
1/22/2013 9:19:29 PM	Allergan To Acquire MAP Pharmaceuticals In $958 Mln Deal
1/22/2013 8:52:58 PM	Allergan To Buy MAP Pharma For $25/share - Quick Facts
1/22/2013 8:36:38 PM	Allergan To Acquire MAP Pharmaceuticals For $25/share
1/9/2013 3:09:01 PM	MAP To Present At J.P. Morgan Healthcare Conference; Webcast At 6:30 PM ET
11/26/2012 6:50:27 AM	MAP Pharmaceuticals Inc. (MAPP) Jumped On FDA News
11/23/2012 2:20:32 PM	MAP Pharmaceuticals Inc. (MAPP) Surged After Levadex Resubmission
11/23/2012 9:34:35 AM	MAP Pharmaceuticals Inc. (MAPP) Has Gapped Up Sharply On FDA News
11/21/2012 5:19:46 PM	MAP Pharma Reports FDA Acceptance For Filing Of NDA Resubmission For LEVADEX
11/21/2012 5:11:36 PM	MAP Pharma Announces FDA Acceptance For Filing Of NDA Resubmission For LEVADEX
11/1/2012 5:06:17 PM	MAP Pharmaceuticals Posts Q3 Loss Per Share Of $0.38 Vs. Profit $0.26 Year Ago
10/16/2012 8:00:01 AM	MAP Pharm Resubmits NDA To FDA For Levadex Orally Inhaled Migraine Drug
10/16/2012 7:02:08 AM	MAP Pharma Resubmits NDA To FDA For LEVADEX Orally Inhaled Migraine Drug

Previous 20 Headlines